← Leaderboards
Michael D Stein
Boston University Medical Campus
$43,083,732
Attributed
$59,441,426
Total exposure
46
Grants
30
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$66,847,733 · 47
By mechanism
R01$45,604,432 · 22
P01$7,406,307 · 1
T32$3,644,127 · 1
R34$2,995,570 · 5
R21$2,816,848 · 7
UH3$999,068 · 1
Top collaborators
- Ana M Abrantes20 shared
- Lisa A Uebelacker18 shared
- Risa B Weisberg10 shared
- Mari-Lynn Drainoni6 shared
- Genie Bailey5 shared
- Jennifer E Johnson5 shared
- Megan M Pinkston5 shared
- Rachel Sayko Adams3 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Vin Tangpricha$645,229
- Risa B Weisberg$7,454,637
- Stephanie C Licata$1,027,655
- Emily Elizabeth Hurstak$813,240
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsPersonsParticipantBaseCaringOpioidBehavioralMedicalBehavior TherapyAddictionRandomizedPrimary Health CarePrimary OutcomeProgramsFollow-UpLifeClinical TrialsMethadoneMeetingsBuprenorphineEnrollmentRandomized Clinical TrialsOpiate AddictionCraving
Grant awards (170)
Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC)$1,501,303
P01 · FY2025 · AA · contact PI
BUP - BOOSTeR: Behavioral Optimization for Overcoming Suboptimal Treatment Retention$739,353
R01 · FY2025 · DA · contact PI
A Longitudinal EMA Study Examining the Role of Maternal Mood and Physical Symptoms on Women's Cannabis Use Across the Perinatal Period$634,396
R01 · FY2025 · DA
tDCS to Decrease Opioid Relapse$496,284
UH3 · FY2025 · DA
Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE)$423,777
T32 · FY2025 · DA · contact PI
Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC)$1,373,231
P01 · FY2024 · AA · contact PI
Optimization and multi-site feasibility of yoga for chronic pain in people in treatment for opioid use disorder$732,955
R01 · FY2024 · AT
A Longitudinal EMA Study Examining the Role of Maternal Mood and Physical Symptoms on Women's Cannabis Use Across the Perinatal Period$648,909
R01 · FY2024 · DA
tDCS to Decrease Opioid Relapse$502,784
UH3 · FY2024 · DA
Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE)$444,113
T32 · FY2024 · DA · contact PI
Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC)$154,763
P01 · FY2024 · AA · contact PI
Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC)$1,430,823
P01 · FY2023 · AA · contact PI
Optimization and multi-site feasibility of yoga for chronic pain in people in treatment for opioid use disorder$763,909
R01 · FY2023 · AT
A Longitudinal EMA Study Examining the Role of Maternal Mood and Physical Symptoms on Women's Cannabis Use Across the Perinatal Period$690,242
R01 · FY2023 · DA
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings$667,113
R01 · FY2023 · DA · contact PI
Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE)$430,476
T32 · FY2023 · DA · contact PI
Methadone-Maintained Smokers Switching to E-Cigarettes$342,159
R01 · FY2023 · DA
Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC)$1,452,137
P01 · FY2022 · AA · contact PI
Optimization and multi-site feasibility of yoga for chronic pain in people in treatment for opioid use disorder$772,575
R01 · FY2022 · AT
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings$749,568
R01 · FY2022 · DA · contact PI
Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE)$422,337
T32 · FY2022 · DA · contact PI
Methadone-Maintained Smokers Switching to E-Cigarettes$351,574
R01 · FY2022 · DA
Examining Highly Palatable Food Consumption upon Initiation of Methadone Maintenance Treatment$200,771
R21 · FY2022 · DA
Optimization and multi-site feasibility of yoga for chronic pain in people in treatment for opioid use disorder$37,558
R01 · FY2022 · AT
Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC)$1,494,050
P01 · FY2021 · AA · contact PI
Optimization and multi-site feasibility of yoga for chronic pain in people in treatment for opioid use disorder$763,073
R01 · FY2021 · AT
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings$757,372
R01 · FY2021 · DA · contact PI
Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE)$513,908
T32 · FY2021 · DA
Methadone-Maintained Smokers Switching to E-Cigarettes$364,626
R01 · FY2021 · DA
Examining Highly Palatable Food Consumption upon Initiation of Methadone Maintenance Treatment$242,299
R21 · FY2021 · DA
Optimization and multi-site feasibility of yoga for chronic pain in people in treatment for opioid use disorder$122,939
R01 · FY2021 · AT
Optimization and multi-site feasibility of yoga for chronic pain in people in treatment for opioid use disorder$811,028
U01 · FY2020 · AT
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings$754,072
R01 · FY2020 · DA · contact PI
Improving Functioning in HIV Patients with Chronic Pain and Comorbid Depressive Symptoms$591,911
R01 · FY2020 · NR · contact PI
Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE)$507,778
T32 · FY2020 · DA
Peer-Facilitated Physical Activity Intervention Delivered During Methadone Maintenance$212,069
R33 · FY2020 · DA
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings$780,578
R01 · FY2019 · DA · contact PI
Improving Functioning in HIV Patients with Chronic Pain and Comorbid Depressive Symptoms$464,391
R01 · FY2019 · NR · contact PI
tDCS to Decrease Opioid Relapse$413,319
UG3 · FY2019 · DA
Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE)$410,556
T32 · FY2019 · DA
Peer-Facilitated Physical Activity Intervention Delivered During Methadone Maintenance$228,573
R33 · FY2019 · DA
tDCS to decrease opioid relapse$129,053
UG3 · FY2019 · DA
Comparing Brief Alcohol Interventions for HIV-HCV Co-infected Persons$480,822
R01 · FY2018 · AA · contact PI
Improving Functioning in HIV Patients with Chronic Pain and Comorbid Depressive Symptoms$452,065
R01 · FY2018 · NR · contact PI
Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE)$330,443
T32 · FY2018 · DA
tDCS to Decrease Opioid Relapse$309,903
UG3 · FY2018 · DA
Peer-Facilitated Physical Activity Intervention Delivered During Methadone Maintenance$218,842
R33 · FY2018 · DA
Yoga to Treat Chronic Pain in Persons Receiving Opioid Agonist Therapy$211,017
R34 · FY2018 · AT
Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence$195,825
R34 · FY2018 · DA · contact PI
A Machine Learning Approach for Inferring Alcohol Intoxication Levels from Gait Data$176,960
R21 · FY2018 · AA · contact PI
Preventing Bacterial and Viral Infections among Injection Drug Users$553,820
R01 · FY2017 · DA · contact PI
AA Linkage for Alcohol Abusing Women Leaving Jail$505,834
R01 · FY2017 · AA · contact PI
Comparing Brief Alcohol Interventions for HIV-HCV Co-infected Persons$486,205
R01 · FY2017 · AA · contact PI
Improving Functioning in HIV Patients with Chronic Pain and Comorbid Depressive Symptoms$461,308
R01 · FY2017 · NR · contact PI
A Machine Learning Approach for Inferring Alcohol Intoxication Levels from Gait Data$228,107
R21 · FY2017 · AA · contact PI
Yoga to Treat Chronic Pain in Persons Receiving Opioid Agonist Therapy$215,505
R34 · FY2017 · AT
Peer-Facilitated Physical Activity Intervention Delivered During Methadone Maintenance$209,717
R21 · FY2017 · DA
Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence$195,698
R34 · FY2017 · DA · contact PI
A Smartphone App to Facilitate Buprenorphine Discontinuation$181,955
R21 · FY2017 · DA · contact PI
Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE)$160,739
T32 · FY2017 · DA
AA Linkage for Alcohol Abusing Women Leaving Jail$505,834
R01 · FY2016 · AA · contact PI
Comparing Brief Alcohol Interventions for HIV-HCV Co-infected Persons$497,195
R01 · FY2016 · AA · contact PI
Improving Functioning in HIV Patients with Chronic Pain and Comorbid Depressive Symptoms$492,565
R01 · FY2016 · NR · contact PI
Linking Opioid Dependent Patients from Inpatient Detoxification to Primary Care$475,128
R01 · FY2016 · DA · contact PI
Preventing Bacterial and Viral Infections among Injection Drug Users$455,837
R01 · FY2016 · DA · contact PI
A Smartphone App to Facilitate Buprenorphine Discontinuation$232,361
R21 · FY2016 · DA · contact PI
Yoga to Treat Chronic Pain in Persons Receiving Opioid Agonist Therapy$226,860
R34 · FY2016 · AT · contact PI
Peer-Facilitated Physical Activity Intervention Delivered During Methadone Maintenance$223,516
R21 · FY2016 · DA
Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence$203,791
R34 · FY2016 · DA · contact PI
Reducing STIs in Emerging Adults Who Use Alcohol and Marijuana$546,747
R01 · FY2015 · AA · contact PI
AA Linkage for Alcohol Abusing Women Leaving Jail$490,659
R01 · FY2015 · AA · contact PI
Comparing Brief Alcohol Interventions for HIV-HCV Co-infected Persons$483,262
R01 · FY2015 · AA · contact PI
Linking Opioid Dependent Patients from Inpatient Detoxification to Primary Care$477,241
R01 · FY2015 · DA · contact PI
Preventing Bacterial and Viral Infections among Injection Drug Users$451,763
R01 · FY2015 · DA · contact PI
Engaging HIV Patients in Primary Care by Promoting Acceptance$203,781
R34 · FY2015 · MH · contact PI
Behavioral Consultation for HIV+ Older Adults Prescribed Opioids for Chronic Pain$181,173
R21 · FY2015 · DA · contact PI
Reducing STIs in Emerging Adults Who Use Alcohol and Marijuana$548,071
R01 · FY2014 · AA · contact PI
Comparing Brief Alcohol Interventions for HIV-HCV Co-infected Persons$508,387
R01 · FY2014 · AA · contact PI
AA Linkage for Alcohol Abusing Women Leaving Jail$490,660
R01 · FY2014 · AA · contact PI
Linking Opioid Dependent Patients from Inpatient Detoxification to Primary Care$480,526
R01 · FY2014 · DA · contact PI
Preventing Bacterial and Viral Infections among Injection Drug Users$458,989
R01 · FY2014 · DA · contact PI
Behavioral Consultation for HIV+ Older Adults Prescribed Opioids for Chronic Pain$225,702
R21 · FY2014 · DA · contact PI
Engaging HIV Patients in Primary Care by Promoting Acceptance$203,640
R34 · FY2014 · MH · contact PI
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings$192,717
R34 · FY2014 · DA · contact PI
AA Linkage for Alcohol Abusing Women Leaving Jail$529,116
R01 · FY2013 · AA · contact PI
Reducing STIs in Emerging Adults Who Use Alcohol and Marijuana$521,799
R01 · FY2013 · AA · contact PI
Preventing Bacterial and Viral Infections among Injection Drug Users$482,807
R01 · FY2013 · DA · contact PI
Linking Opioid Dependent Patients from Inpatient Detoxification to Primary Care$461,306
R01 · FY2013 · DA · contact PI
Linkage of Hospitalized Opioid Users to Buprenorphine$310,833
R01 · FY2013 · DA · contact PI
Distress Tolerance and Reducing Early Relapse in Buprenorphine Patients$267,300
R34 · FY2013 · DA · contact PI
Engaging HIV Patients in Primary Care by Promoting Acceptance$215,575
R34 · FY2013 · MH · contact PI
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings$184,809
R34 · FY2013 · DA · contact PI
Treating Chronic Pain and Depression in HIV Patients in Primary Care Settings$160,699
R21 · FY2013 · NR · contact PI
Marijuana and Sleep in Young Adults$144,635
R21 · FY2013 · DA · contact PI
Reducing STIs in Emerging Adults Who Use Alcohol and Marijuana$519,046
R01 · FY2012 · AA · contact PI
Linking Opioid Dependent Patients from Inpatient Detoxification to Primary Care$498,068
R01 · FY2012 · DA · contact PI
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers$450,265
R01 · FY2012 · CA · contact PI
Linkage of Hospitalized Opioid Users to Buprenorphine$318,018
R01 · FY2012 · DA · contact PI
Distress Tolerance and Reducing Early Relapse in Buprenorphine Patients$278,438
R34 · FY2012 · DA · contact PI
Treating Chronic Pain and Depression in HIV Patients in Primary Care Settings$221,874
R21 · FY2012 · NR · contact PI
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings$200,614
R34 · FY2012 · DA · contact PI
Marijuana and Sleep in Young Adults$187,079
R21 · FY2012 · DA · contact PI
Reducing STIs in Emerging Adults Who Use Alcohol and Marijuana$541,799
R01 · FY2011 · AA · contact PI
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers$483,584
R01 · FY2011 · CA · contact PI
Linkage of Hospitalized Opioid Users to Buprenorphine$354,029
R01 · FY2011 · DA · contact PI
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers$504,188
R01 · FY2010 · CA · contact PI
Linkage of Hospitalized Opioid Users to Buprenorphine$359,504
R01 · FY2010 · DA · contact PI
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers$119,558
R01 · FY2010 · CA · contact PI
Mid-Career Investigator Award in Substance Abuse - Research$117,408
K24 · FY2010 · DA · contact PI
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers$505,271
R01 · FY2009 · CA · contact PI
Linkage of Hospitalized Opioid Users to Buprenorphine$375,556
R01 · FY2009 · DA · contact PI
INSOMNIA AND DRUG RELAPSE RISK$293,865
R01 · FY2009 · DA · contact PI
Mid-Career Investigator Award in Substance Abuse - Research$117,097
K24 · FY2009 · DA · contact PI
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers$111,515
R01 · FY2009 · CA · contact PI
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers$461,848
R01 · FY2008 · CA · contact PI
A Brief Marijuana Intervention for Adolescent Women$337,546
R01 · FY2008 · DA · contact PI
INSOMNIA AND DRUG RELAPSE RISK$293,353
R01 · FY2008 · DA · contact PI
Antidepressants During Office-based Buprenorphine$263,476
R01 · FY2008 · DA · contact PI
Mid-Career Investigator Award in Substance Abuse - Research$116,793
K24 · FY2008 · DA · contact PI
Antidepressants During Office-based Buprenorphine$53,621
R01 · FY2008 · DA · contact PI
TADALAFIL AND RAYNAULD'S DISEASE$750
M01 · FY2008 · RR · contact PI
INHERITABILITY OF CYP3A ACTIVITY$35
M01 · FY2008 · RR · contact PI
A Brief Marijuana Intervention for Adolescent Women$437,003
R01 · FY2007 · DA · contact PI
A BRIEF ALCOHOL INTERVENTION FOR INCARCERATED WOMEN$374,825
R01 · FY2007 · AA · contact PI
Antidepressants During Office-based Buprenorphine$352,397
R01 · FY2007 · DA · contact PI
INSOMNIA AND DRUG RELAPSE RISK$318,732
R01 · FY2007 · DA · contact PI
Mid-Career Investigator Award in Substance Abuse - Research$116,500
K24 · FY2007 · DA · contact PI
A BRIEF ALCOHOL INTERVENTION FOR INCARCERATED WOMEN$32,040
R01 · FY2007 · AA · contact PI
TADALAFIL AND RAYNAULD'S DISEASE$15,914
M01 · FY2007 · RR · contact PI
INHERITABILITY OF CYP3A ACTIVITY$746
M01 · FY2007 · RR · contact PI
A BRIEF ALCOHOL INTERVENTION FOR INCARCERATED WOMEN$545,318
R01 · FY2006 · AA · contact PI
A Brief Marijuana Intervention for Adolescent Women$420,606
R01 · FY2006 · DA · contact PI
Antidepressants During Office-based Buprenorphine$375,047
R01 · FY2006 · DA · contact PI
INSOMNIA AND DRUG RELAPSE RISK$328,251
R01 · FY2006 · DA · contact PI
Mid-Career Investigator Award in Substance Abuse - Research$116,214
K24 · FY2006 · DA · contact PI
A BRIEF ALCOHOL INTERVENTION FOR INCARCERATED WOMEN$504,014
R01 · FY2005 · AA
A Brief Marijuana Intervention for Adolescent Women$417,825
R01 · FY2005 · DA
INSOMNIA AND DRUG RELAPSE RISK$323,145
R01 · FY2005 · DA
Smoking Cessation Among Methadone Maintained Patients$273,795
R01 · FY2005 · CA
MIDCAREER INVESTIGATOR AWARD IN SUBSTANCE ABUSE RESEARCH$79,592
K24 · FY2005 · DA
GENETIC VARIABILITY AND VASCULAR RESPONSE$6,908
M01 · FY2005 · RR
A BRIEF ALCOHOL INTERVENTION FOR INCARCERATED WOMEN$492,460
R01 · FY2004 · AA
A Brief Marijuana Intervention for Adolescent Women$410,479
R01 · FY2004 · DA
Smoking Cessation Among Methadone Maintained Patients$344,845
R01 · FY2004 · CA
MIDCAREER INVESTIGATOR AWARD IN SUBSTANCE ABUSE RESEARCH$79,592
K24 · FY2004 · DA
Genetic Variability and Vascular Response$52,269
M01 · FY2004 · RR
Adapting to HIV Disease--A Family Intervention$1
R01 · FY2004 · MH
MAINTAINING HIV RISK REDUCTION AMONG NEEDLE EXCHANGERS$1
R01 · FY2004 · MH
Adapting to HIV Disease--A Family Intervention$487,369
R01 · FY2003 · MH
A BRIEF ALCOHOL INTERVENTION FOR INCARCERATED WOMEN$477,692
R01 · FY2003 · AA
MAINTAINING HIV RISK REDUCTION AMONG NEEDLE EXCHANGERS$475,997
R01 · FY2003 · MH
A TRIAL TO REDUCE HEPATITIS C AMONG INJECTION DRUG USERS$371,720
R01 · FY2003 · DA
Smoking Cessation Among Methadone Maintained Patients$175,823
R01 · FY2003 · CA
MIDCAREER INVESTIGATOR AWARD IN SUBSTANCE ABUSE RESEARCH$79,592
K24 · FY2003 · DA
A TRIAL TO REDUCE HEPATITIS C AMONG INJECTION DRUG USERS$502,458
R01 · FY2002 · DA
Adapting to HIV Disease--A Family Intervention$477,798
R01 · FY2002 · MH
MAINTAINING HIV RISK REDUCTION AMONG NEEDLE EXCHANGERS$474,286
R01 · FY2002 · MH
Smoking Cessation Among Methadone Maintained Patients$432,789
R01 · FY2002 · CA
ANTIDEPRESSANT TREATMENT TO REDUCE HIV RISK AMONG IDUS$382,617
R01 · FY2002 · MH
MIDCAREER INVESTIGATOR AWARD IN SUBSTANCE ABUSE RESEARCH$79,592
K24 · FY2002 · DA
A TRIAL TO REDUCE HEPATITIS C AMONG INJECTION DRUG USERS$502,845
R01 · FY2001 · DA
ANTIDEPRESSANT TREATMENT TO REDUCE HIV RISK AMONG IDUS$475,432
R01 · FY2001 · MH
Adapting to HIV Disease--A Family Intervention$473,963
R01 · FY2001 · MH
MAINTAINING HIV RISK REDUCTION AMONG NEEDLE EXCHANGERS$469,131
R01 · FY2001 · MH
Smoking Cessation Among Methadone Maintained Patients$440,334
R01 · FY2001 · CA
MIDCAREER INVESTIGATOR AWARD IN SUBSTANCE ABUSE RESEARCH$79,592
K24 · FY2001 · DA
ANTIDEPRESSANT TREATMENT TO REDUCE HIV RISK AMONG IDUS$483,989
R01 · FY2000 · MH
A TRIAL TO REDUCE HEPATITIS C AMONG INJECTION DRUG USERS$483,303
R01 · FY2000 · DA
MAINTAINING HIV RISK REDUCTION AMONG NEEDLE EXCHANGERS$442,964
R01 · FY2000 · MH
Adapting to HIV Disease--A Family Intervention$440,976
R01 · FY2000 · MH